← Leaderboards
Jaime Uribarri
Icahn School Of Medicine At Mount Sinai
$365,464
Attributed
$730,927
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$730,927 · 1
By mechanism
R01$730,927 · 1
Top collaborators
- Michal Schnaider Beeri1 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Michal Schnaider Beeri$14,706,707
- Panagiotis Roussos$45,081,240
- Vahram Haroutunian$39,970,462
- Rosalind J Wright$130,075,643
- Kecia Nicole Carroll$15,572,155
Others in their field
Other Emerging Leaders on “Advanced Glycosylation End Products”
- Raja G Khalifah · Praetego, Inc.$5,752,037
- Colleen Bauza · Jaeb Center For Health Research, Inc.$4,053,339
- Viral N Shah · University Of Colorado Denver$2,628,424
- Guowei Su · Glycan Therapeutics Corporation$2,405,945
- Malia Michelle Edwards · Johns Hopkins University$2,372,735
- Maria Luiza A Caramori · University Of Minnesota$2,306,563
Research focus
Advanced Glycosylation End ProductsAffectAgingAging PopulationAlzheimer&AposAmericanAmyloidAutopsyBaseBrainBrain HealthBrain PathologyBrain TissueCerebrovascular DisordersCerebrumCessation Of LifeClinical DataClinical TrialsClinical Trials DesignCognitionCognitive TestingCommunitiesComplementAdult